Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Evaluating closed-loop treatment for atrial fibrillation

Official title: Application of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population in the Northern Shanghai Community

Run by Shanghai 10th People's Hospital · NCT05311137 · Data updated 2026-11-12

This study tests a new treatment method for people with atrial fibrillation to see if it can improve their care and health outcomes after undergoing a specific heart procedure.

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment5000 (estimated)
SponsorShanghai 10th People's Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedMay 1, 2022
Main results expectedJanuary 1, 2024
Study endsJanuary 1, 2032
Registry record updatedMay 24, 2022
Trial IDNCT05311137 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with atrial fibrillation who can understand and sign informed consent.

Probably not a fit

Patients who do not have atrial fibrillation or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a closed-loop treatment approach for patients with atrial fibrillation, focusing on optimizing treatment strategies and improving disease outcomes. It aims to enhance patient understanding of atrial fibrillation and assess the economic implications of this treatment concept within the northern Shanghai community. The study involves monitoring patients who undergo radiofrequency ablation as part of their treatment plan.

Why it matters

Potential benefit: If successful, this approach could lead to improved management and outcomes for patients with atrial fibrillation.

How similar studies have gone: While the concept of closed-loop treatment is innovative, similar approaches in managing atrial fibrillation have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* atrial fibrillation patients;Ability to act autonomously, understand and sign informed consent;

Exclusion Criteria:

* none(All patients with atrial fibrillation were enrolled in this study indiscriminately and followed up)

Where it's running

  • Shanghai Tenth People's Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.